Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Hengrui Medicine: HRS9531 Injection Drug Clinical Trial Approved
People’s Finance and Information, March 26, Hengrui Pharmaceuticals (600276) announced on March 26 that recently, the company’s subsidiary Fujian Shengdi Pharmaceutical Co., Ltd. received from the National Medical Products Administration the approved and issued “Notification of Approval for Drug Clinical Trials” regarding HRS9531 injection, and clinical trials will be conducted in the near term. The indication being applied for is: to reduce the risk of major cardiovascular adverse events in patients with atherosclerotic cardiovascular disease.